"Pittsburgh reinvented itself from steel to medicine — and that reinvention hasn't reached every neighborhood. Pitt trains physicians who understand that the future of healthcare must serve the communities that built this city."
"Western Pennsylvania has an opioid crisis shaped by mill closures, injury, and despair. It has an aging population that outlived its industries. It has neighborhoods where steel-era pollution still shows up in asthma and cancer rates. These are your patients."
"A 58-year-old retired steelworker in McKeesport presents with chronic pain after a workplace injury. He has been on opioids for 8 years, has struggled with use disorder, and is deeply resistant to tapering. He lives alone since his wife's death and has limited social support. What factors shape your approach and what ethical tensions do you face?"
Practice this scenario with AI →the Jesse Gelsinger gene therapy case is a foundational research ethics story that Pitt faculty helped shape the response to.
Western PA's opioid crisis has specific roots in mill closures, occupational injury, and social despair.
organ allocation, social factors in listing decisions, and living donor protection are deep ethical areas.
Pittsburgh's air quality and industrial pollution are ongoing public health issues with direct clinical consequences.
"In 14 years of examining I have never failed a candidate for giving the 'wrong' answer. I have failed candidates for how they treated the person in the room with them."
Jesse Gelsinger was an 18-year-old who died in a gene therapy trial at the University of Pennsylvania in 1999. The case revealed serious failures: inadequate informed consent, undisclosed COI, and disregard for safety signals.
Know that the case led to an overhaul of federal research oversight, including stricter IRB requirements and financial COI disclosure rules.
Practice connecting this case to present-day research ethics questions: what has changed since 1999, what structural risks remain?
Western PA's opioid crisis is specifically linked to occupational injury in steel and coal industries, followed by over-prescribing, followed by heroin and fentanyl as prescription access tightened.
Practice the chronic pain / opioid use disorder overlap scenario — patients with real pain who also have use disorder face the most complex ethical management.
Know the specific resources available in Pittsburgh: harm reduction coalitions, medication-assisted treatment networks, the PA opioid trust fund programs.
UPMC is one of the world's leading transplant centers — students here will encounter transplant ethics in clinical training. Know the UNOS allocation system and how social factors (stable housing, social support) legitimately vs. problematically affect listing decisions.
Practice the living donor protection argument: what safeguards ensure a living kidney donor isn't being pressured or inadequately informed?
Know the "alcoholic liver disease" listing debate — whether patients with AUD should be required to demonstrate sobriety before liver transplant, and whether this is evidence-based or stigmatizing.
Pitt asked me about a chronic pain patient who refused to taper opioids. The station was about how you navigate patient autonomy, addiction risk, and the limits of prescribing. Know your position on opioid tapering ethics — not just the clinical guidelines.
I got a transplant ethics station about a patient who was denied listing because of housing instability. They wanted me to reason through whether social factors are legitimate in allocation decisions — know both the utilitarian and the justice arguments.
The Jesse Gelsinger case came up in a research ethics station. Know it cold — not just that someone died, but what specific failures caused it and what changed in research oversight afterward.